deals

Deals (w/e 10/31/25)

Lee McCabe

31 Oct 2025 — 1 min read

Francisco Partners Takes Jamf Private in $2.2 Billion Deal

Francisco Partners is taking Jamf private in a $2.2 billion all-cash deal at $13.05 per share, marking an exit for Vista Equity, which held a 34% stake. Jamf manages and secures Apple devices for enterprises, posting ~$176.5 million in Q2 revenue, up 15% year-over-year, but continued to bleed cash in public markets. Francisco’s play is textbook PE arbitrage—take a sticky, recurring-revenue SaaS business out of Wall Street’s spotlight, strip overhead, and rebuild margins through tighter cost control and bolt-ons. Jamf’s single-ecosystem focus gives it defensible moats but also growth ceilings. If Francisco can unlock profit without choking innovation, this could be a smart medium-term compounder. Deal strength: high-medium. Link

Ponte Partners Quietly Snaps Up U.S. Tech Company

Ponte Partners, the San Francisco investment firm, announced the acquisition of an undisclosed U.S. technology company. Details—name, price, or segment—weren’t shared, but Ponte typically targets smaller, cash-generative tech and business-services companies in the $2 million-to-$100 million range. The opacity here suggests a quiet carve-out or founder sale, the kind of off-market transaction where operational tightening and digital discipline can create quick multiple expansion. It’s not headline material, but it signals that smaller tech deals are still moving even as big sponsors slow. Deal strength: moderate. Link

News (w/e 1/9/26)

Eir Partners Closes $1 Billion Fund Focused on Healthcare Technology Miami-based Eir Partners closed its third fund at $1 billion, blowing past its $800 million target in just a few months. The raise reinforces a clear LP preference: specialist healthcare investors with repeatable playbooks still get paid attention, even as

Deals (w/e 1/9/26)

Veritas Capital Buys Majority Stake in Global Healthcare ExchangeVeritas Capital is acquiring a majority stake in Global Healthcare Exchange (GHX), the healthcare supply-chain software platform used by hospitals and suppliers across the U.S. GHX sits in the unglamorous but essential plumbing of healthcare, where scale and data matter more

Private equity has quietly entered a new sport: competitive talent hoarding.

Every firm now appears to be stockpiling operators the way children collected Pokémon cards. Operating Partners, Senior Advisors, Venture Partners, EIRs—hand out a title, add them to a slide, declare victory. LPs love the imagery. It signals “capability.” It looks sophisticated. It gives the impression of a tightly coordinated

AI isn’t coming for middle management. It’s already rearranging the job description.

The layer of people whose primary function is aggregating information, writing summaries, building decks, and “managing up” is about to feel the shift first. Not because AI is more insightful than they are, but because it’s cheaper, faster, and doesn’t need three pre-meetings to prepare for the meeting.